期刊文献+

我院利奈唑胺使用情况调查

下载PDF
导出
摘要 采用回顾性调查方法,查阅2010年1月至2010年12月我院29例使用利奈唑胺治疗的患者的病历,分析研究患者病情、药物联用、细菌培养及药敏试验等情况,评价临床用药合理性。结果 29例患者均为危重症患者,联合用药者居多,达20例(68.96%);合理及基本合理用药22例(75.86%),不合理用药19例(65.5%);发生药品不良反应3例(10.34%);17例(58.6%)培养出细菌,15例根据药敏试验调整用药。
出处 《海峡药学》 2013年第2期234-236,共3页 Strait Pharmaceutical Journal
基金 常州市科技局指导性课题,项目(CS20109014).
  • 相关文献

参考文献9

  • 1汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2008年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2009,9(5):321-329. 被引量:423
  • 2宁东,吕小鸥,陈凤芬,伍康志.耐甲氧西林葡萄球菌的临床感染特点及耐药性分析[J].中华医院感染学杂志,2011,21(2):384-386. 被引量:14
  • 3田磊,李丽,张蓓,陈中举.武汉地区医院感染葡萄球菌的耐药性监测[J].中国微生态学杂志,2009,21(2):161-162. 被引量:4
  • 4Goldrick B. First reported case of VRSA in the United States[J]. Am J Nurs,2003,102 ( 11 ) :17.
  • 5殷凯生,殷民生.使用抗感染药物手册[M].第1版.北京:人民卫生出版社,2001.463-485.
  • 6于新蕊,张培城.对利奈唑胺临床安全性和耐药性的评估[J].国外医药(抗生素分册),2004,25(2):95-95. 被引量:6
  • 7C, erson S, Kaphm S, Bruss J, et aL Hematologic effects of linezolid: summary of clinical experience [ J]. Antimicrob Agents Chemother, 2002,46( 8 ) :2723-2725.
  • 8Birmingham MC, Rayner CR, Meagher AK, et aL Linezolid for the treatment of multidrag-resistant, Grampositive infections: experience from a compassionate-use program [J]. Clin Infect Dis,2003,36 ( 2 ) : 159-161.
  • 9Garazzino S, De Rosa FG, Bargiacchi O. Haematological safety of long- term therapy with linezolid [J]. I nt J Antimicrob Agents ,2007,29 (4) : 480-482.

二级参考文献21

  • 1郭晨雯,范春,王京鹰,傅金英.两种葡萄球菌耐药性的变迁[J].医药导报,2005,24(8):736-737. 被引量:2
  • 2王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 3TENOVER F C, BIDDL E J W, LANCASTER M V. Increasing resistance to vancomycin and orther glycopeptides in Staphylococcus aureus [ J ]. Emerg Infect Dis ,2001,7 (2) :327-332.
  • 4DOMARACKI B E,EVANS A,PRESTON K E,et al. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci[J]. Eur J Clin Microbiol Infect Dis,1998,17(3) :143-150.
  • 5CUI L Z, MURAKAMI H, KUWAHARA A K, et al. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancemycin resistance expressed by staphylococcus aureus Mu50 [ J ]. Antim icrob Agents Chemother,2000,44(9) :2276-2280.
  • 6Clinical and I.aboratory Standards Institute(CLSI). Perform ance standards for Antimicrobial susceptibility testing[S]. M100-S17, 2007.
  • 7Clinical and Laboratory Standards Institute (CLSI). Perform anee standards for Antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 8Bratu S, I.andman D, Haag R, et al. Rapid spread of carbapenem resistant Klebsiella pneumoniae in New York City: anew threat to our antibiotic armamentarium[J]. Arch Int Meal.2005,165(12) :1430-1435.
  • 9Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA [J]. J Antimierob Chemother, 2009, 63(3):427-437.
  • 10Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenem resistant Acinetobacter baumannii producing the OXA- 23 β- lactamase in Korea[J]. J Clin Microbiol, 2005, 43(5):2241 -2245.

共引文献444

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部